| Title | Neuro-Oncology Advances |
| Standard Abbreviation | Neuro-Oncol. Adv. |
| Type of Publication | Journal |
| Discipline | Neurology (clinical) (Q1); Oncology (Q1); Surgery (Q1) |
| Impact Score | 4.02 |
| SCImago Journal Rank (SJR) | 1.421 |
| h-index | 42 |
| Overall Rank | 2675 |
| Publisher Name | Oxford University Press |
| Publication Country | United Kingdom |
| International Standard Serial Number (ISSN) | 26322498 |
| Coverage and History | 2019-2026 |
| Best Quartile | Q1 |
| Total Citations Received (Last 3 Year) |
2238 |
Neuro-Oncology Advances is a journal published by Oxford University Press. This journal covers the area[s] related to Neurology (clinical), Oncology, Surgery, etc.
The coverage history of this journal is as follows: 2019-2026.
The rank of this journal is 2675. This journal's impact score, h-index, and SJR are 4.02, 42, and 1.421, respectively. The ISSN of this journal is/are as follows: 26322498.
The best quartile of Neuro-Oncology Advances is Q1.
This journal has received a total of 2238 citations during the last three years (Preceding 2025).
The latest impact score (IS) of the Neuro-Oncology Advances is 4.02. It is computed in the year 2026 as per its definition and based on Scopus data.
4.02
It is increased by a factor of around 0.59, and the percentage change is 17.2% compared to the preceding year 2024, indicating a rising trend.
The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact Score 2025 of Neuro-Oncology Advances is 4.02. If a similar upward trend continues, IS may increase in 2026 as well.
| Year | Impact Score (IS) |
|---|---|
| 2026/2027 | Coming Soon |
| 2025 | 4.02 |
| 2024 | 3.43 |
| 2023 | 3.60 |
| 2022 | 3.47 |
| 2021 | 2.95 |
| 2020 | 1.68 |
| 2019 | 0.00 |
The h-index of Neuro-Oncology Advances is 42. By definition of the h-index, this journal has at least 42 published articles with more than 42 citations.
The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.
The International Standard Serial Number (ISSN) of Neuro-Oncology Advances is/are as follows: 26322498.
The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.
ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}
The Neuro-Oncology Advances is ranked 2675 among 27955 Journals, Conferences, and Book Series.
As per SJR, this journal is ranked 1.421.
SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
The publisher of Neuro-Oncology Advances is Oxford University Press. The publishing house of this journal is located in the United Kingdom. Its coverage history is as follows: 2019-2026.
Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).
The International Organization for Standardization 4 (ISO 4) abbreviation of Neuro-Oncology Advances is Neuro-Oncol. Adv.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).
As ISO 4 is an international standard, the abbreviation ('Neuro-Oncol. Adv.') can be used for citing, indexing, abstraction, and referencing purposes.
If your area of research or discipline is related to Neurology (clinical), Oncology, Surgery, etc., please check the journal's official website to understand the complete publication process.
There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:
The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.
The latest impact score of Neuro-Oncology Advances is 4.02. It is computed in the year 2026.
The latest h-index of Neuro-Oncology Advances is 42. It is evaluated in the year 2026.
The latest SCImago Journal Rank (SJR) of Neuro-Oncology Advances is 1.421. It is calculated in the year 2026.
The latest ranking of Neuro-Oncology Advances is 2675. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2026.
Neuro-Oncology Advances is published by Oxford University Press. The publication country of this journal is United Kingdom.
This standard abbreviation of Neuro-Oncology Advances is Neuro-Oncol. Adv..
Neuro-Oncology Advances is a journal published by Oxford University Press.
The scope of Neuro-Oncology Advances is as follows:
For detailed scope of Neuro-Oncology Advances, check the official website of this journal.
The International Standard Serial Number (ISSN) of Neuro-Oncology Advances is/are as follows: 26322498.
The best quartile for Neuro-Oncology Advances is Q1.
The coverage history of Neuro-Oncology Advances is as follows 2019-2026.
Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.
| Journal/Conference/Book Title | Type | Publisher | Ranking | SJR | h-index | Impact Score |
|---|---|---|---|---|---|---|
| Historia | Journal | Universidade Estadual Paulista (UNESP) | 19366 | 10 | 0.23 | |
| SPE Production and Operations Symposium, Proceedings | Conference And Proceedings | 15907 | 21 | 0.00 | ||
| Clinical Medicine and Research | Journal | Marshfield Clinic | 14142 | 66 | 1.34 | |
| International Journal of Mathematical Education in Science and Technology | Journal | Taylor and Francis Ltd. | 7829 | 48 | 1.43 | |
| Discourse | Journal | Routledge | 7630 | 75 | 2.82 | |
| SPE International Formation Damage Control Symposium Proceedings | Conference And Proceedings | 21934 | 16 | 0.00 | ||
| International Journal of Pest Management | Journal | Taylor and Francis Ltd. | 14557 | 60 | 1.87 | |
| European Journal of Wildlife Research | Journal | Springer Verlag | 11509 | 65 | 1.80 | |
| Transboundary and Emerging Diseases | Journal | John Wiley and Sons Ltd | 6140 | 100 | 2.50 | |
| Geo-Info | Journal | Nederlandse Vereniging voor Kartografie | 30490 | 2 | 0.00 |
| Year | Impact Score (IS) |
|---|---|
| 2026/2027 | Updated Soon |
| 2025 | 4.02 |
| 2024 | 3.43 |
| 2023 | 3.60 |
| 2022 | 3.47 |
| 2021 | 2.95 |
| 2020 | 1.68 |
| 2019 | 0.00 |
4.02
1.421
42
2675
